OBJECTIVE: The cerebellum is a key structure involved in coordinated motor planning, cognition, learning and memory functions. This study presents a permanent model of a toxin produced cerebellar lesion characterized according to contemporary motor and cognitive abnormalities. MATERIALS AND METHODS: In this experimental study, slow administration of quinolinic acid (QA, 5 µl of 200 µmol, 1 µl/minute) in the right cerebellar hemisphere (lobule VI) caused noticeable motor and cognitive disturbances along with cellular degeneration in all treated animals. We assessed behavioral and histopathological studies over ten weeks after QA treatment. The data were analyzed with ANOVA and the student's t test. RESULTS: The QA treated group showed marked motor learning deficits on the rotating rod test (p=0.0001), locomotor asymmetry on the cylinder test (p=0.0001), dysmetria on the beam balance test (p=0.0001), abnormalities in neuromuscular strength on the hang wire test (p=0.0001), spatial memory deficits in the Morris water maze (MWM, p=0.001) and fear conditioned memory on the passive avoidance test (p=0.01) over a ten-week period compared with the control animals. Histopathological analysis showed loss of Purkinje cells (p=0.001) and granular cell density (p=0.0001) in the lesioned hemisphere of the cerebellum. CONCLUSION: Results of the present study show that QA can remove numerous cells which respond to this toxin in hemispheric lobule VI and thus provide a potential model for functional and cell-based studies.
OBJECTIVE: The cerebellum is a key structure involved in coordinated motor planning, cognition, learning and memory functions. This study presents a permanent model of a toxin produced cerebellar lesion characterized according to contemporary motor and cognitive abnormalities. MATERIALS AND METHODS: In this experimental study, slow administration of quinolinic acid (QA, 5 µl of 200 µmol, 1 µl/minute) in the right cerebellar hemisphere (lobule VI) caused noticeable motor and cognitive disturbances along with cellular degeneration in all treated animals. We assessed behavioral and histopathological studies over ten weeks after QA treatment. The data were analyzed with ANOVA and the student's t test. RESULTS: The QA treated group showed marked motor learning deficits on the rotating rod test (p=0.0001), locomotor asymmetry on the cylinder test (p=0.0001), dysmetria on the beam balance test (p=0.0001), abnormalities in neuromuscular strength on the hang wire test (p=0.0001), spatial memory deficits in the Morris water maze (MWM, p=0.001) and fear conditioned memory on the passive avoidance test (p=0.01) over a ten-week period compared with the control animals. Histopathological analysis showed loss of Purkinje cells (p=0.001) and granular cell density (p=0.0001) in the lesioned hemisphere of the cerebellum. CONCLUSION: Results of the present study show that QA can remove numerous cells which respond to this toxin in hemispheric lobule VI and thus provide a potential model for functional and cell-based studies.
Cerebellar disorders cause motor abnormalities
due to infectious illness, injuries or hereditary
degenerative processes in the brain. They are
characterized by extreme incoordination, gait impairment,
disordered eye movements, poor articulation,
impaired swallowing, and tremors (1-3).Beside its function in motor harmonization, the
cerebellum acts in cognitive processes such as consideration,
verbal studying, working memory, and
sensory discrimination. The role of the cerebellum
in cognition has generated considerable debate (4-
8). Several studies have examined whether damage
in the cerebellum disrupts learning on cognitive
tasks similar to that observed in motor learning.
For instance, Fiez et al. (9) have proposed that cerebellar
damage causes a decline paired-associate learning
and semantic recovery (10). It has been proven
that, through a link with the thalamus, the cerebellum
innervates not only motor regions of the cortex, but also prefrontal and parietal heteromodal association
cortices implicated in cognition (11-14). As a result
of cerebellar damage, neurocognitive symptoms and
a cognitive affective syndrome that consist of slower
results and mental disorders have been proven (15).
In addition, lesions of the lateral cerebellum impair
cognitive functions, resulting in mutism and amnestic
aphasia (14). The cerebellar hemisphere in connection
with the dorsolateral prefrontal cortex is involved in
executive and working memory functions (16-20).Signs of cerebellar ataxia include significant loss
of Purkinje and granular cells. These cells have functional
N -Methyl Di Aspartic Acid (NMDA) receptors
(21). Purkinje and granular cells involuntarily
stimulate or stimulation occurs when cells are infused
with glutamatergic afferents (21-23). Quinolinic
acid (QA) is a selective NMDA receptor agonist
(24). The acute neurotoxic effects of QA in the brain
are attached with extracellular Ca2+ and direct to hyperphysiological
Ca2+ condensations into the cell.
Enhanced Ca2+ levels promote apoptosis pathway
with their excitotoxic function (25).According to previous research, the cerebellum
may have a distinct functional topography, with the
superior posterior regions mediating certain specific
cognitive processes (26, 27). The left superiorposterior
lobe of the cerebellum is associated with
visual-spatial memory and the right superior-posterior
lobe of the cerebellum mediates a planning
component of executive functioning (26-28).As a result of the cerebellar functional topography
and anatomical studies of projections between the
cerebellum and cerebral cortices it has been hypothesized
that the advanced motor tasks would activate
regions of the cerebellum to which sensorimotor regions
project, namely lobules IV-VI and lobule VIII
(29, 30). However, evidences have shown that cognitive
tasks predominantly activate lobules VI and
VII (31). Therefore, this study sought to develop a
permanent model of toxin produced cerebellar abnormalities
by focal intra-cerebellar injection of QA into
hemispheric lobule VI.
Materials and Methods
Quinolinic acid-induced lesions
All experiments were carried out in accordance
with the Guidelines of the Animal Care of Ferdowsi
University of Mashhad, approved by the University
Animal Ethics Committee. Animals were kept
on a normal day-night cycle (12 hours/12 hours,
lights at 07:00), standard temperature (25 ± 2℃)
and humidity conditions. Animals were fed lab
chow and tap water ad libitum.Adult male Wistar rats (270-300 g) were used in
this study. Animals (n=20) were anesthetized by a
mixture of ketamine hydrochloride (30 mg/kg) and
xylazine (4 mg/kg) and then positioned in a stereotaxic
apparatus. All rats received a stereotaxic lesion
in the right cerebellar hemisphere (lobule VI) via a
single 2 μl injection of QA (200 μmol, Merck, Germany)
dissolved in 0.1 M phosphate buffer saline
(PBS) which was administered by a 5G-Hamilton
syringe at the following coordinates: AP=11.96 mm,
ML=2.96 mm, and DV=4.0 mm from the bregma.
QA was slowly injected over a period of 5 minutes;
the needle was left in position for another 4 minutes
and then gently removed. Rats (n=20) in the vehicletreated
group received injections of PBS in the same
stereotaxic coordinates. After recovery from surgery,
rats were returned to their cages and assessed daily for
neurological function.
Motor function assessment
Rotarod
The accelerating rotarod apparatus (47700, Ugo
Basile, Italy) was used to assess balance and coordination
by measuring the amount of time the animal
was able to remain on a longitudinally rotating
rod. During the training period, rats were placed
on the rotarod starting at a speed 5 rpm which was
slowly increased to 40 rpm. The maximum observation
time was 5 minutes. Animals were tested
with four trials per week with a 1 hour between
trials. The latency to fall during the observation
period was recorded. Rotarod data was analyzed
by ANOVA statistical tests (n=20).
Cylinder test
One week after QA injection, all rats were assessed
for motor function via the cylinder test. The cylinder
encourages use of the forelimbs for vertical exploration
and landing after a rearing movement (32, 33).
Animals were placed in a transparent plastic cylinder
(20 cm diameter, 30 cm height) and videotaped until
they had performed 20 rears while making contact
with the walls of the cylinder. The test was carried out
in two successive trials with one hour interval over
a ten-week period (one testing session per week)
following the QA injection. The proportion of paw use (impaired/normal) was counted (total of 20 paw
placements per trial).
Beam walking test
The beam walking task consisted of placing the rats
on an elevated (100 cm) narrow wooden beam (3 cm
wide) held 30 cm above the ground with a large 40
cm2 platform at one end (34). Animals were trained
to traverse the beam prior to testing. An animal was
considered to have mastered the task when it spontaneously
crossed the entire 100 cm length of the beam
without falling off, for three consecutive trials each
day over a three-day period. The distance moved
along the beam was recorded as 100 cm if the animal
traversed the entire beam successfully or was measured
from the rear of the hind limbs at the point where
the animal fell. The total time taken to cross the beam,
including the time where animal was immobile on the
beam, was recorded along with the time spent moving.
Testing was conducted for three trials per day, for
a 10-week period.
Hanging wire test
This task was used as a measure of muscular
strength and motor neuron integrity (35). Rats utilized
their forelimbs to suspend their body weight on a wire
(0.5 cm in diameter, 60 cm length) that was stretched
between two posts and located 20 cm above a foam
pillow. The time (in seconds) until the rat fell was recorded.
A score of zero was assigned if the rat fell immediately
and 60 seconds was the timeout period for
a 10-week period after QA injection.
Cognitive function tests
Morris water maze: Acquisition of spatial learning
Spatial learning was assessed in a Morris water
maze (MWM) apparatus. This test was shown to be
a measure of cognitive function and dysfunction after
QA injection (36, 37). The maze consisted of a plastic
pool (180 cm diameter, 60 cm height) filled with
tap water (26 ± 1˚C) to a depth of 28 cm that was
located in a room with salient visual cues. The hidden
platform was a clear Plexiglas stand positioned
in the southeast quadrant and held constant for each
rat. Animals were tested with four trials per day, over
five consecutive days at three weeks post injection.
Each trial was initiated by placing the animal at one of
four randomly chosen locations, facing the wall of the
tank. Animals were allowed to search for the hidden
platform for a period of 60 seconds. If an animal failed
to find the platform, it was placed on the platform by
the researcher and allowed to remain there for a period
of 30 seconds before being returned to a warming
cage for a five-minute period between trials. For each
trial, movement within the maze was monitored by a
video camera linked to tracking software. The latency
to platform was calculated as the time necessary to
locate the hidden platform. Using the tracking software,
we calculated time spent swimming in circles
and swim speed. Animals’ performances in spatial acquisition
were analyzed using the repeated measure
one-way ANOVA.
Passive avoidance test
We used the passive avoidance learning test based
on negative reinforcement to examine long-term
memory (38). The passive avoidance test was conducted
by using an apparatus that consisted of two
separate chambers (light and dark chambers) connected
to a computer. Each chamber was separated
by a small guillotine door and grids were attached on
the floor in the dark chamber. This test comprised the
following three sessions at five weeks post-injection.
First, a step through ‘Trials to Criterion’ procedure
was used in the training session on the first and second
day. During the test session (day three), rats were
individually placed in the light chamber. Immediately
after the rats entered the dark chamber, the door was
locked and an electrical stimulation of 2 mA and 50
Hz was applied for 2 seconds. In the retention session
(day four) which was performed 24 hours later, rats
were again placed in the light chamber and the time
spent in this chamber before entering the dark chamber,
within five minutes, was measured. The latency
in the retention session was expressed graphically and
used in data analysis.
Animal sacrifice and tissue analysis
After completion of behavioral testing (at the
end of ten weeks post-injection), the animals were
terminally anesthetized with an intra-peritoneal
injection of a mixture of ketamine hydrochloride
(100 mg/kg) and xylazine (5 mg/kg) and intracardially
perfused with 0.9% saline followed by
10% phosphate-buffered formalin. After fixation,
the brains were removed and post-fixed in 10%
phosphate-buffered formalin for seven days. The
brains were then blocked to remove the forebrain,
after which the cerebellum was paraffin-embedded
and sectioned on a microtome in 5 μm sections.
Sections were deparaffinized, serially hydrated,
stained with hematoxylin-eosin (H&E), and then cover-slipped for tissue analysis.
Neurotoxic lesion area
Using a macro objective (Nikon 1X, Nikon, Japan),
a photomicrograph (Nikon Eclipse E600)
was obtained of each coronal section throughout
the cerebellum of each animal by a systematic random
procedure. Image analysis software (ImageJ,
National Institute of Health) was used to outline
the lesion, if present, and to calculate the area for
each section. Using Cavalieri’s principle an estimate
of total neurotoxic lesion areas per animal
was calculated in cubic millimeters.
Purkinje cell counting
Design-based stereology was performed to count
Purkinje cells in lobule VI in H&E stained sections. A
total of 15 sections were used for obtaining Purkinje
cell counts. The Purkinje cell layer was identified at ×2
magnification on live microscopic images displayed
in a stereological computer microscopy system.
Purkinje cells with a visible nucleolus were counted
by visual inspection under a ×40 objective, Purkinje
cells were marked if they were positive. We counted
the total number of Purkinje cells in all sections. For
each animal, we randomly chose and analyzed 15 sections
that contained all lobules of the cerebella hemispheres
(intact and lesion hemisphere). All Purkinje
cell numbers were averaged to obtain one value per
lesion and intact hemispheres of groups.
Granular cell density
We obtained estimates of the total numbers of H&E
stained cells in the granular cell layer of the cerebellum
in the both hemispheres per rat. Light microscope
photographs were taken of the granular cell nucleus.
The images were processed with Image J software.
In each cerebellar section, neurons were counted at
×100 amplification. The size of the counting frames
was 50×50 mm for grids of 120×120 mm. Neurons
were counted if their somata were found within the
counting frames (three frames were created by the
software and placed at the intersections of a grid) or
overlapping its top-right border. We obtained an unbiased
estimate of the granular cell number for each
section. H&E staining was performed on 9-10 sections
sampled in an even distribution across the tissue,
which provided appropriate sampling to apply
the stereological cell count method (39).
Statistical analysis
The data were collected by observers blinded to
treatment conditions and analyzed using repeatedmeasures
ANOVA, with time as the repeated measure.
All group comparisons were analyzed using
either the student’s t test or Tukey’s post hoc test
to account for multiple comparisons and to determine
which groups significantly differed from one
another. A significance level of p<0.05 was used
for all tests. Values are presented as mean ± SEM.
Results
Motor performance
There were statistically significant differences
in the based beam walking test between groups.
Longer beam-walk times were observed in the lesioned
rats (n=20, Fig 1A) compared to the controls
(Fig 1B) for all times tested (n=20, p≤0.0001
vs. non-lesioned for all motor tests).
Fig 1
Motor performance: By ten weeks post-lesion, the
quinolinic acid (QA)-lesioned group began to develop weakness
on the beam walking test, as evidenced by the time spent
on the beam (A) and the speed (B) when compared with nonlesioned
rats (vehicle treated rats, *p≤0.0001). In the motor
learning task, rotarod (C), the QA-lesioned group showed a
behavioral deficit from the first week which continued up to
ten weeks (*p≤0.0001). Complete loss of motor coordination
was observed in the QA-lesioned group in the rotarod test.
The lesioned group failed to stay on the rotating rod even
after ten weeks. Animals’ function on the cylinder test (D)
after QA lesioning were assessed as the proportion of limb
use (impaired/normal). After a QA lesion in the right cerebellum’s
hemisphere, rats in the lesioned group rarely used
their impaired forelimb to explore the cylinder wall during
the ten weeks of testing compared with vehicle-treated rats
(*p≤0.0001). In the hanging wire test (E) QA-treated rats
showed less latency to fall from the wire than non-lesioned
rats (vehicle treated rats,* p ≤ 0.0001). All error bars indicate
standard error of mean (SEM).
Rotarod test
All animals (n=20) showed deterioration in the
rotarod scores at one week post-injury. Rotarod
motor testing revealed significant decreases in
falling latency in QA-injected rats compared with
vehicle treated rats (n=20) during ten weeks after
the lesion (Fig 1C, p≤0.0001).Vehicle-treated rats (n=20) made a majority of
double contacts on the cylinder wall during their explorative
behavior and used each limb to explore the
cylinder with the same frequency and proportion of
limb use (impaired/normal) was 0.8966 ± 0.011. After
infliction of the QA lesion, lesioned rats (n=20)
held their impaired forelimb in a rigid tight position
and rarely used the impaired forelimb to explore the
cylinder. Therefore, the lesioned group showed a dramatic
decrease in the proportion of double contacts
due to decreased spontaneous use of the contralateral
forepaw (Fig 1D, p≤0.0001).
Wire hanging test
The wire hanging ability of the rats with QA lesions
decreased. The mean latency time to fall of
the QA-injected group (n=20) was significantly
less than that of the vehicle treated rats (n=20)
during ten weeks post-lesion (Fig 1E, p≤0.0001).
These results indicated that the QA injection significantly
disturbed neuromuscular strength in this
model.Motor performance: By ten weeks post-lesion, the
quinolinic acid (QA)-lesioned group began to develop weakness
on the beam walking test, as evidenced by the time spent
on the beam (A) and the speed (B) when compared with nonlesioned
rats (vehicle treated rats, *p≤0.0001). In the motor
learning task, rotarod (C), the QA-lesioned group showed a
behavioral deficit from the first week which continued up to
ten weeks (*p≤0.0001). Complete loss of motor coordination
was observed in the QA-lesioned group in the rotarod test.
The lesioned group failed to stay on the rotating rod even
after ten weeks. Animals’ function on the cylinder test (D)
after QA lesioning were assessed as the proportion of limb
use (impaired/normal). After a QA lesion in the right cerebellum’s
hemisphere, rats in the lesioned group rarely used
their impaired forelimb to explore the cylinder wall during
the ten weeks of testing compared with vehicle-treated rats
(*p≤0.0001). In the hanging wire test (E) QA-treated rats
showed less latency to fall from the wire than non-lesioned
rats (vehicle treated rats,* p ≤ 0.0001). All error bars indicate
standard error of mean (SEM).
Cognitive performance
Morris water maze
The data for this test of spatial memory showed
statistically significant differences in the latency
to reach the fixed invisible platform by the MWM
test (F value: 128.987, p≤0.001). For both groups,
there were comparable latency and path length
measures from day one in learning to locate the
platform.Post-hoc testing demonstrated significantly
increased latencies to locate the hidden platform
in the QA-injected group compared to
the control group on subsequent days (Fig 2A).
Swim speed did not significantly differ between
the groups (F value: 1.448, p≤0.233, Fig 2B)
which suggested that accurate assessment of
place learning was not precluded by extraneous
factors such as motor disparities. These data
suggested that QA-injected animals (n=20) had
more difficulty in learning the location of the
platform compared with control animals (n=20)
and exhibited a memory deficit after the hemispheric
lobule VI injury.
Fig 2
Cognitive performance:
Three weeks post-lesion, animals were tested in the Morris
water maze (MWM) task. Animals were tested using four
trials per day for latency (A) and speed (B) to reach the
hidden platform, which was recorded after each trial. Quinolinic
acid (QA)-treated rats showed longer latencies to
the hidden platform than non-lesioned rats (vehicle treated,
F value: 128.987, *p≤0.001). Swimming speed was not
significant between the groups (F value: 1.448, p≤0.233).
A comparison of the delay times (to enter) and total stay
times in the dark electrical foot shock box (before and
after shock) was tested in the passive avoidance test (C).
These profiles showed statistically significant differences
between vehicle and QA-treated groups at 48 hours after
shock (**p=0.008 for latency to entry and *p=0.016 for
time spent in dark room). There were no significant differences
before and after the shock in each group.
We determined the putative differences in the
passive avoidance test for the two experimental
groups by measuring the time taken by the rat to
enter the dark compartment after the door was
opened. This test was conducted at five weeks
post-lesion (Fig 2C). Based on our data, there
were no significant differences between groups
in the time spent before entering the dark compartment
and time in the dark compartment in
the acquisition session. The latencies were 12.11
± 0.21 seconds (n =20) for the vehicle-treated
group (control) and 14.67 ± 0.3 seconds (n=20)
for lesioned animals. The total staying time in
the dark electrical foot shock box was 237.60 ±
10.4 seconds for the control group and 224.84
± 9.08 seconds for the QA-injected group. In
contrast, for the retention session performed 48
hours after the first session, two-way ANOVA
showed a significantly longer retention time for
non-lesioned rats that moved into the dark compartment
compared with the lesioned group (F
value: 8.795, p=0.008). Control group showed
longer latency (204.87 ± 11.28 seconds) whereas
the QA-injected group showed a significantly
lower value (58.604 ± 4.003 seconds). These
results suggested a difference in the retention
performance of the control versus lesioned
group. The QA-injected group remained the
longest (193.5 ± 9.31 seconds) in the dark box
during the entire follow-up period; the control
rats stayed 50.29 ± 4.3 seconds (F value: 6.931,
p=0.016, Fig 2C). Therefore, it could be concluded
that in the passive avoidance test, QAinjected
animals had significant memory deficits
compared to the control animals.Cognitive performance:Three weeks post-lesion, animals were tested in the Morris
water maze (MWM) task. Animals were tested using four
trials per day for latency (A) and speed (B) to reach the
hidden platform, which was recorded after each trial. Quinolinic
acid (QA)-treated rats showed longer latencies to
the hidden platform than non-lesioned rats (vehicle treated,
F value: 128.987, *p≤0.001). Swimming speed was not
significant between the groups (F value: 1.448, p≤0.233).
A comparison of the delay times (to enter) and total stay
times in the dark electrical foot shock box (before and
after shock) was tested in the passive avoidance test (C).
These profiles showed statistically significant differences
between vehicle and QA-treated groups at 48 hours after
shock (**p=0.008 for latency to entry and *p=0.016 for
time spent in dark room). There were no significant differences
before and after the shock in each group.Hematoxylin-eosin (H&E) staining:Quinolinic acid (QA) injection site in schematic (A) and real
(B) pictures. In the lesioned hemisphere there is Purkinje
cell loss (C) compared to the right cerebellar hemisphere of
control rats (D). Granular cell density is decreased in the
right cerebellar hemisphere of QA-treated rat (E), while it
is intact in right hemisphere of vehicle-treated rat (F). The
scale bar is 100 μm. Arrows shows PCL. ML; Molecular
layer, PCL; Purkinje cell layer and GL; Granular layer.
Histological analysis
Purkinje cells counts and neurotoxic lesion area
H&E staining demonstrated that the numbers of
Purkinje cells in the right hemispheres of animals
in the QA-injected group were less compared
to the number of Purkinje cells in right
hemisphere of vehicle treated rats (Fig 3C).
After stereological analysis, we observed a significant
decrease in the total number of Purkinje
cells in the QA-injected group compared
to control animals (Fig 4A, F value: 11.738;
p≤0.001). We evaluated the neurotoxic lesion
area and noted a significant difference between
the groups (Fig 4C, F value: 15.816; p<0.001).
As seen in figure 3B, compared to vehicle
treated rats, animals that received a single dose
of QA (5 μl of 200 μmol) in the right cerebellar
hemisphere demonstrated significantly increased
mean neurotoxic lesion areas (15.141 ±
2.1 mm3) compared to the control group (0.232
± 0.002 mm3).
Fig 3
Hematoxylin-eosin (H&E) staining:
Quinolinic acid (QA) injection site in schematic (A) and real
(B) pictures. In the lesioned hemisphere there is Purkinje
cell loss (C) compared to the right cerebellar hemisphere of
control rats (D). Granular cell density is decreased in the
right cerebellar hemisphere of QA-treated rat (E), while it
is intact in right hemisphere of vehicle-treated rat (F). The
scale bar is 100 μm. Arrows shows PCL. ML; Molecular
layer, PCL; Purkinje cell layer and GL; Granular layer.
Fig 4
Stereological analysis:
Average of Purkinje cell numbers in 15 random sections of
the right hemisphere in the quinolinic acid (QA) and vehicle-
treated groups after hematoxylin-eosin (H&E) staining
(A). Histograms showed that the number of Purkinje cells
was significantly reduced in right hemisphere of QA-treated
rats compared with vehicle treated rats as controls (F value:
11.738, *p≤ 0.001). Granular cell density was decreased in
right hemisphere of QA-treated rats compared with controls
(B, F value=45.785, **p≤0.0001). In the neurotoxic lesion
area (C), a significant between-group difference was found
(F value: 15.816, *p≤0.001).
Granular cell density
Based on histological analysis, we observed
decreased granular cell density in the QA-treated
group compared with control rats (Fig 3E, F).
Among animals at ten weeks post-injury, significant
group differences existed in terms of the
granular cell layer estimated cell density (Fig 4B,
F value=45.785, p≤0.0001).Stereological analysis:Average of Purkinje cell numbers in 15 random sections of
the right hemisphere in the quinolinic acid (QA) and vehicle-
treated groups after hematoxylin-eosin (H&E) staining
(A). Histograms showed that the number of Purkinje cells
was significantly reduced in right hemisphere of QA-treated
rats compared with vehicle treated rats as controls (F value:
11.738, *p≤ 0.001). Granular cell density was decreased in
right hemisphere of QA-treated rats compared with controls
(B, F value=45.785, **p≤0.0001). In the neurotoxic lesion
area (C), a significant between-group difference was found
(F value: 15.816, *p≤0.001).
Discussion
Most neurodegenerative diseases, including cerebellar degeneration, lead to severe behavioral abnormalities in mammals. Although classically considered to be involved only in motor coordination, the cerebellum has more recently been implicated in cognitive control (40, 41). The right cerebellum in relation to the dorsolateral prefrontal cortex is involved in executive and working memory operations such as subvocal rehearsal mechanisms of verbal working memory (40-42). Neuropsychological studies in patients with degenerative cerebellar ataxia have shown the presence of cognitive dysfunction, mainly of the executive type (43). Our results have indicated that the QA lesioned cerebellar hemisphere contributed to some of the cognitive deficits observed in the MWM task and passive avoidance test. Further studies are necessary to determine all of the cortical areas of the cerebellum that participate in non-motor functions.Stoodley and Schmahmann (31) have proposed a separation among sensorimotor and cognitive cerebellum. Sensorimotor cerebellum includes the hemispheres of the frontal lobe, lobulus simplex (lobules HV and HVI), and paramedian lobule (HVIII). The cognitive cerebellum consists of HVI, Crus I and II and the lobule HVIIB of the posterior lobe. In a meta-analysis of neuroimaging studies of functional topography within the cerebellum, both lobule VI and crus I of VIIA in the superior-posterior lobes have been found to be consistently activated during executive function tasks (30). Hemispheric lobule VI was specifically activated during spatial tasks (29, 44, 45). We confirmed that hemispheric lobule VI was implicated in memory processing, skill learning and motor coordination in the rat model of a hemispheric lobule VI lesion.However, recent reports have shown that Purkinje cells in folia VI-IX are more vulnerable because of their motor coordination function and that the less vulnerable folia are involved in cognition (46). In the current study’s model, QA could destroy a large area of hemispheric lobule VI (Fig 3B), causing a decrease in Purkinje and granular cells. QA specifically affected memory task as well as motor coordination.The beam walking test, rotarod, and hanging wire test have been used in order to differentiate between animals that have lost different cell populations in the cerebellum. These tests show sensitivity to cerebellar lesions and different levels of severity have been delineated depending on the type of cerebellar degeneration studied (47, 48).The cerebellar lesions in QA-injected rats showed time-related deficits. We examined motor deficits by rotarod, beam walking, hanging wire and cylinder tests at ten weeks post-injection. The results showed the presence of permanent motor impairments and functional deficits in the QA-treated group even at ten weeks after injury.QA is a potential model for cerebellar disorder. The NMDA receptor agonist causes partial loss of Purkinje cells that mimic progressive clinical deterioration. We have recently shown that this model is suitable for stem cell transplantation (49). This is a significant advantage over genetic models of disease where there is a total loss of Purkinje cells together with a variable number of surviving supporting cells (50).
Conclusion
Our data indicate that local lesions in cerebellar lobule VI lead to impairments in motor performance and memory functions. The effect of QA on hemispheric lobule IV has enabled us to develop an acute focal neurotoxic lesion in the cerebellum. Future anatomical, physiological and imaging studies in animal models and humans will clarify the precise role of cerebellar organization and its connections in motor learning, sensorimotor control and cognition tasks. This paper has attempted to show some aspects of cerebellar functions in hemispheric lobule VI and provide further support for a cerebellar role in both motor and cognitive tasks, in addition to a better establishment of the existence of lobule VI function in the cerebellum.
Authors: Hanne Baillieux; Werner Verslegers; Philippe Paquier; Peter P De Deyn; Peter Mariën Journal: Clin Neurol Neurosurg Date: 2008-03-04 Impact factor: 1.876
Authors: Gabriel Crevier-Sorbo; Vladimir V Rymar; Raphael Crevier-Sorbo; Abbas F Sadikot Journal: Acta Neuropathol Commun Date: 2020-02-07 Impact factor: 7.801